BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3098650)

  • 1. [Evaluation of therapeutic plasmapheresis].
    Shechter Y; Sharon R
    Harefuah; 1986 Aug; 111(3-4):65-6. PubMed ID: 3098650
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasmapheresis, an aid in the treatment of patients with active systematic lupus erythematosus?].
    Houwert DA; Kater L; Struyvenberg A
    Ned Tijdschr Geneeskd; 1978 May; 122(19):678-81. PubMed ID: 148592
    [No Abstract]   [Full Text] [Related]  

  • 3. [Initial plasmapheresis treatment results in glomerulonephritis].
    Nenov D; Stanchev I; Chankova P
    Vutr Boles; 1981; 20(2):105-8. PubMed ID: 7257329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasmapheresis on blood fractionators].
    Kalinin NN; Petrova VI; Movshev BE; Petrov MM; Dubrovina NA
    Sov Med; 1988; (12):23-6. PubMed ID: 3149425
    [No Abstract]   [Full Text] [Related]  

  • 5. The therapeutic potential of plasmapheresis in systemic lupus erythematosus (SLE).
    Swaak AJ
    Neth J Med; 1988 Oct; 33(3-4):155-9. PubMed ID: 3226448
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of the blood cell system in pregnant women with Rh isoimmunization treated by plasmapheresis].
    Gabryś M; Woytoń J; Bielanów T; Geneja R; Woytoń P
    Wiad Lek; 1989 Dec; 41(23):1563-5. PubMed ID: 2503941
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plasmapheresis in Rh isoimmunization. Monitoring various parameters of blood crasis and coagulation].
    Noia G; Pompa G; Virgolino A; Rosati P; Lanti T; Bellati U
    Minerva Ginecol; 1986 Mar; 38(3):109-17. PubMed ID: 3085027
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of plasmapheresis in active systemic lupus erythematosus.
    Kater L; Derksen RH; Houwert DA; Hené RJ; Struyvenberg A; Gmelig Meyling FH; Verroust P
    Neth J Med; 1981; 24(6):209-16. PubMed ID: 7322246
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of plasmapheresis on T anc B lymphocyte functions in patients with systemic lupus erythematosus: a double blind study.
    Tsokos GC; Balow JE; Huston DP; Wei N; Decker JL
    Clin Exp Immunol; 1982 May; 48(2):449-57. PubMed ID: 6213330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of the treatment of Rh serologic incompatibility by plasmapheresis].
    Woytoń J; Zalewski J; Gabryś M; Zimmer M; Pieńkowski W; Orlik-Adamska S; Runge T
    Acta Haematol Pol; 1988; 19(3-4):202-4. PubMed ID: 3150895
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of Rh-isoimmunized pregnant women with plasmapheresis].
    Molnár GB; Pál A; Kalmár F; Mészáros E; Kaiser G; Kovács L
    Orv Hetil; 1987 Feb; 128(6):291-5. PubMed ID: 3103043
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy with corticoid pulses, plasmapheresis, and corticoid pulses combined with plasmapheresis in systemic lupus erythematosus].
    Carreira PE; Gómez-Reino JJ; Morillas L; Mateo I; Ibero I; Millet VG; Páramo MJ
    Med Clin (Barc); 1986 Jun; 87(5):179-82. PubMed ID: 3736247
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of plasmapheresis in the treatment of systemic lupus erythematosus].
    Leibowitz G; Ben-Yehuda A; Naparstek Y
    Harefuah; 1990 Mar; 118(6):329-33. PubMed ID: 2189809
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic plasmapheresis in the combined therapy of systemic lupus erythematosus (a case report)].
    Kalinin NN; Pashinin AN; Alekberova ZS; Folomeev MIu; Kliukvina NG
    Ter Arkh; 1993; 65(7):85-6. PubMed ID: 8211790
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of the use of plasmapheresis in the treatment of Rh incompatibility].
    Czeszyńska M; Cretti A; Rzechuła H; Malinowska-Szutowicz Z
    Acta Haematol Pol; 1988; 19(1-2):47-55. PubMed ID: 3149110
    [No Abstract]   [Full Text] [Related]  

  • 16. [Initial experience in the treatment of systemic lupus erythematosus using plasmapheresis].
    Simcíková B; Opat P; Rysánek K; Bucek J; Lokaj J; Podrouzková D; Mayer P
    Cas Lek Cesk; 1985 Aug; 124(35):1097-101. PubMed ID: 4028096
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasmapheresis in the treatment of systemic lupus erythematosus.
    Błaszczyk M; Chorzelski T; Daszyński J; Gaczkowski A; Jabłońska S; Beutner EH
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):769-72. PubMed ID: 6983871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of the treatment of serologic incompatibility by plasmapheresis].
    Woytoń J; Gabryś M; Bielanów T; Geneja R; Woytoń P
    Wiad Lek; 1988 Oct; 41(20):1361-5. PubMed ID: 3149818
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of plasmapheresis in a patient with systemic lupus erythematosus and necrotizing cutaneous ulcers.
    Fruchter L; Gauthier B; Marino F
    J Rheumatol; 1983 Apr; 10(2):341-3. PubMed ID: 6864694
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasmapheresis and subsequent pulse cyclophosphamide in severe systemic lupus erythematosus. An interim report of the Lupus Plasmapheresis Study Group.
    Euler HH; Guillevin L
    Ann Med Interne (Paris); 1994; 145(5):296-302. PubMed ID: 7985935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.